Talis Biomedical Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Talis Biomedical.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 16.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
We're A Little Worried About Talis Biomedical's (NASDAQ:TLIS) Cash Burn Rate
Aug 16
Talis Biomedical reports Q2 results
Aug 02Talis Biomedical Aims For Manufacturing Turnaround
Mar 17Talis Biomedical (NASDAQ:TLIS) Will Have To Spend Its Cash Wisely
Feb 08Is Talis Biomedical (NASDAQ:TLIS) In A Good Position To Deliver On Growth Plans?
Nov 04Is Talis Biomedical (NASDAQ:TLIS) In A Good Position To Deliver On Growth Plans?
Jul 21News Flash: 4 Analysts Think Talis Biomedical Corporation (NASDAQ:TLIS) Earnings Are Under Threat
May 18Talis Biomedical Corporation (NASDAQ:TLIS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
May 14In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Talis Biomedical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 2 | -62 | -54 | -53 | N/A |
| 9/30/2023 | 2 | -75 | -56 | -55 | N/A |
| 6/30/2023 | 3 | -86 | -67 | -65 | N/A |
| 3/31/2023 | 3 | -98 | -74 | -73 | N/A |
| 12/31/2022 | 5 | -113 | -102 | -100 | N/A |
| 9/30/2022 | 5 | -115 | -130 | -127 | N/A |
| 6/30/2022 | 5 | -127 | -184 | -181 | N/A |
| 3/31/2022 | 4 | -165 | -195 | -193 | N/A |
| 12/31/2021 | 8 | -192 | -174 | -171 | N/A |
| 9/30/2021 | 8 | -208 | -172 | -167 | N/A |
| 6/30/2021 | 17 | -199 | -134 | -125 | N/A |
| 3/31/2021 | 18 | -144 | -113 | -104 | N/A |
| 12/31/2020 | 11 | -91 | -95 | -87 | N/A |
| 9/30/2020 | 12 | -1 | -62 | -56 | N/A |
| 12/31/2019 | 4 | 26 | -25 | -24 | N/A |
| 12/31/2018 | 2 | -21 | -21 | -21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if TLIS's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if TLIS's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if TLIS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if TLIS's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if TLIS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TLIS's Return on Equity is forecast to be high in 3 years time